- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 39/04 - Chelating agents
Patent holdings for IPC class A61P 39/04
Total number of patents in this class: 196
10-year publication summary
|
6
|
7
|
10
|
8
|
5
|
8
|
11
|
11
|
14
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Centre National de La Recherche Scientifique | 10516 |
10 |
| The Regents of the University of California | 20059 |
8 |
| Uop LLC | 4241 |
6 |
| Universite Claude Bernard Lyon 1 | 1028 |
5 |
| Mexbrain | 25 |
5 |
| Chelation Partners Incorporated | 8 |
4 |
| Universite de Bretagne Occidentale | 109 |
4 |
| AustinPx, LLC | 27 |
4 |
| Cornell University | 3329 |
3 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3364 |
3 |
| Institut Curie | 591 |
3 |
| Institut Gustave Roussy | 261 |
3 |
| University of Kansas | 879 |
3 |
| The University of Sydney | 605 |
3 |
| Fe Pharmaceuticals (Canada) Inc. | 4 |
3 |
| Novartis AG | 10730 |
2 |
| Murata Manufacturing Co., Ltd. | 24713 |
2 |
| The Board of Trustees of the University of Illinois | 2713 |
2 |
| University of Florida Research Foundation, Inc. | 4048 |
2 |
| Apotex Technologies Inc. | 16 |
2 |
| Other owners | 119 |